← Back to Search

Other

A Pilot Dose Ranging Study of Spinosad Creme Rinse

Phase 2
Waitlist Available
Led By Dyal Garg, Ph.D.
Research Sponsored by ParaPRO LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
All Individual Drugs Already Approved

Summary

A pilot dose ranging study to evaluate the safety and efficacy of different strengths of Spinosad Creme versus a vehicle control.

Eligible Conditions
  • Head Lice

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.

Trial Design

4Treatment groups
Active Control
Placebo Group
Group I: 3Active Control1 Intervention
1.0% Spinosad Creme Rinse
Group II: 2Active Control1 Intervention
0.5% Spinosad creme rinse
Group III: 4Active Control1 Intervention
2.0% Spinosad Creme Rinse
Group IV: 1Placebo Group1 Intervention
Vehicle control

Find a Location

Who is running the clinical trial?

ParaPRO LLCLead Sponsor
11 Previous Clinical Trials
1,937 Total Patients Enrolled
Dyal Garg, Ph.D.Principal InvestigatorHill Top Research
~2 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top